Company Overview
About Circle Pharma
Circle Pharma is a clinical-stage biopharmaceutical company founded in 2016 by Matthew Jacobson, Siegfried Bhagwati, and Grace Aldrovandi, headquartered in San Francisco, California. The company is developing a new class of therapeutics — cell-permeable macrocycles — designed to inhibit intracellular protein-protein interactions (PPIs) that have historically been considered "undruggable." Protein-protein interactions control critical cellular processes including cell division, apoptosis (programmed cell death), and gene expression. Dysregulation of these interactions drives many cancers, but their large, flat interaction surfaces are difficult to block with small molecules, and biologics (antibodies) cannot cross cell membranes to reach intracellular targets. Circle Pharma's macrocycles are medium-sized ring-shaped molecules engineered to be both cell-permeable and orally bioavailable — a combination rarely achieved — enabling them to reach and inhibit these targets.
Business Model & Competitive Advantage
Circle Pharma combines structure-based drug design with advanced synthetic chemistry to design macrocycles that adopt the three-dimensional shape required to bind specific PPI interfaces. The company's platform systematically generates candidate molecules with drug-like properties: oral bioavailability, cellular permeability, metabolic stability, and selectivity. Its lead programs target intracellular oncology pathways including the MDM2-p53 interaction (relevant to a broad range of cancers) and other PPI targets identified through its structure-biology engine. Unlike kinase inhibitors (the dominant class of cancer targeted therapy), PPI inhibitors can potentially target transcription factors and scaffolding proteins involved in the earliest stages of cancer development.
Competitive Landscape 2025–2026
Circle Pharma raised a $90M Series B in 2023 led by Novo Holdings (the investment arm of the Novo Nordisk Foundation) and Foresite Capital, with participation from Atlas Venture, Novartis Venture Fund, and other investors. This brings total funding to over $130M. The company is advancing its lead candidates toward investigational new drug (IND) applications and initial clinical studies, with ambitions to bring orally delivered PPI inhibitors into cancer clinical trials — a milestone that would validate the macrocycle therapeutic modality for intracellular oncology.
Frequently Asked Questions
Similar Brands
Pliant Therapeutics
Pliant Therapeutics develops small molecule integrin inhibitors targeting the pathological tissue scarring (fibrosis) that drives diseases including idiopathic pulmonary fibrosis (IPF), primary sclero
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Cradle
Cradle is a protein design platform using AI to help biotechnology and pharmaceutical companies engineer better proteins — enzymes, antibodies, and therapeutic proteins — with improved stability, acti
BioNTech
BioNTech SE was founded in 2008 in Mainz, Germany by Ugur Sahin, Ozlem Tureci, and Christoph Huber with a mission to harness the immune system for individualized cancer treatment. The company pioneere
Genentech
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
Compare Circle Pharma with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Circle Pharma? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Circle Pharma Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Circle Pharma vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →